These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1912 related articles for article (PubMed ID: 16166262)

  • 41. Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2.
    Tong SJ; Zhang XY; Guo HF; Yang J; Qi YP; Lu S
    Clin Transl Oncol; 2021 Dec; 23(12):2526-2535. PubMed ID: 34086253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
    Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
    Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes.
    Papadopoulos EI; Yousef GM; Scorilas A
    Biomed Pharmacother; 2015 Mar; 70():33-40. PubMed ID: 25776476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.
    Sampath D; Liu C; Vasan K; Sulda M; Puduvalli VK; Wierda WG; Keating MJ
    Blood; 2012 Feb; 119(5):1162-72. PubMed ID: 22096249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case-control study.
    Davari N; Ahmadpour F; Kiani AA; Azadpour M; Asadi ZT
    BMC Res Notes; 2021 Jan; 14(1):21. PubMed ID: 33430952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.
    Zou ZJ; Fan L; Wang L; Xu J; Zhang R; Tian T; Li JY; Xu W
    Oncotarget; 2015 Jan; 6(2):1276-85. PubMed ID: 25361012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
    Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
    Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of BCL2 by miRNAs augments drug-induced apoptosis--a combined computational and experimental approach.
    Singh R; Saini N
    J Cell Sci; 2012 Mar; 125(Pt 6):1568-78. PubMed ID: 22328513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
    Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
    Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The BH3-only protein Noxa is stimulated during apoptosis of chronic lymphocytic leukemia cells triggered by M2YN, a new plant-derived extract.
    Zaher M; Mirshahi M; Nuraliev Y; Sharofova M; Bombarda I; Marie JP; Billard C
    Int J Oncol; 2011 Oct; 39(4):965-72. PubMed ID: 21750864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of Chlorambucil and Valproic Acid on Cell Viability, Apoptosis and Expression of
    Lipska K; Filip A; Gumieniczek A
    Cells; 2021 May; 10(5):. PubMed ID: 34063233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
    Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
    Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.
    Roberts AW; Seymour JF; Brown JR; Wierda WG; Kipps TJ; Khaw SL; Carney DA; He SZ; Huang DC; Xiong H; Cui Y; Busman TA; McKeegan EM; Krivoshik AP; Enschede SH; Humerickhouse R
    J Clin Oncol; 2012 Feb; 30(5):488-96. PubMed ID: 22184378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
    Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
    Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
    Fedorchenko O; Stiefelhagen M; Peer-Zada AA; Barthel R; Mayer P; Eckei L; Breuer A; Crispatzu G; Rosen N; Landwehr T; Lilienthal N; Möllmann M; Montesinos-Rongen M; Heukamp L; Dürig J; Hallek M; Fingerle-Rowson G; Herling M
    Blood; 2013 May; 121(20):4126-36. PubMed ID: 23547049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
    Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
    Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 96.